A IMPORTÂNCIA DA RESSONÂNCIA MAGNÉTICA NO DIAGNÓSTICO DA HEMOCROMATOSE HEREDITÁRIA

Autores/as

  • Ilana Félix Pinho Faculdade de Ciências Médicas da Santa Casa de São Paulo
  • Leandro Nobeschi Faculdades Metropolitanas Unidas - FMU e Faculdade de Ciências Médicas da Santa Casa de São Paulo
  • Rafael Eidi Goto Faculdade de Ciências Médicas da Santa Casa de São Paulo
  • Bergman Nelson Sanchez Munhoz Faculdades de Ciências Médicas da Santa Casa de São Paulo e Universidade Nove de Julho
  • Homero José de Farias e Melo Faculdade de Ciências Médicas da Santa Casa de São Paulo e São Camilo

Palabras clave:

Hemocromatose hereditária, LIC, ressonância magnética, RSR, relaxometria.

Resumen

A hemocromatose hereditária é uma doença genética relacionada ao acúmulo de ferro no organismo, principalmente no fí­gado.  A biópsia é o "padrão ouro" para o diagnóstico da concentração de ferro no fí­gado (LIC), porém é um método invasivo. Por outro lado, os exames sorológicos são sensí­veis, mas não especí­ficos.  Estudos relacionados à ressonância magnética (RM) tem sido desenvolvidos pois ela é altamente sensí­vel a presença de ferro, destacando-se as técnicas de relação-sinal- ruí­do (RSR) e relaxometria. Os métodos de RSR já são aplicáveis atualmente na prática clí­nica, principalmente o protocolo de Rennes. Já a relaxometria (R2/R2*) gera valores mais precisos do LIC, entretanto exige um investimento de alto custo e não possui protocolos padronizados. A RM é um método não invasivo e com técnicas que possuem potencial para auxiliar e aperfeiçoar o diagnóstico e monitoramento de pacientes com HH.

Citas

Aymone WC, Valiati V, Resem MGFS, Peres W. Hemocromatose hereditária. J Bras Med. 2013;101(6):27-33.

Cancado RD, Chiattone CS. Visão atual da hemocromatose hereditária. Rev Bras Hematol Hemoter. 2010;32(6):469-75.

Pinho R, Fernandes S, Leite S, Pinto J, Afonso M, Silva AP, et al. Revisão das manifestações da hemocromatose a propósito de um caso clí­nico com 25 anos de evolução. J Port Gastroenteol. 2008;15(4):161-7.

Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalassaemia, 2nd revised edition. Thalassaemia International Federation; 2008.

Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45(3):340-6.

Echeverria JMA, Castiella A, Emparanza JI. Quantification of iron in the liver by RMI. Insights Imaging. 2012;3(2):173-80.

Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010;18(3):359-81.

Gandon Y, Olivie D, Guyade D, Aubé C, Oberti F, Sebille V, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363(9406):357-62.

St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 2004;17(7):446-58.

Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106(4):1460-5.

Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: State of the art and remaining challenges. J Magn Reson Imaging. 2014;40(5):1003-21.

Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhé T, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology. 1994;193(2):533-8.

Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology. 1999;212(1):227-34.

Virtanen JM, Komu ME, Parkkola RK. Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. Magn Reson Imaging. 2008;26(8):1175-82.

Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, van der Jagt EJ, Oudkerk M. Non-invasive liver iron concentration measurement by MRI: Comparison of two validated protocols. Eur J Radiol. 2009; 71(1):116-21.

St Pierre TG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci. 2005; 1054:379-85.

Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol. 2006;77(2):145-9.

Castiella A, Alústiza JM, Emparanza JI, Zapata EM, Costero B, Dí­ez MI. Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice? Eur Radiol. 2011;21(1):137-41.

Alustiza JM, Emparanza JI, Castiella A, Casado A, Garrido A, Aldazabal P, et al. Measurement of liver iron concentrationby MRI is reproducible. BioMed Res Int. 2015; 2015:8.

St Pierre TG, Clark PR, Chua-Anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105(2):855-61.

Alexopoulou E, Stripeli F, Baras P, Seimenis I, Kattamis A, Ladis V, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Mag Reson Imaging. 2006;23(2):163-70.

Wood JC, Ghugre N. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008; 32(1-2):85-96.

Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18(1):33-9.

Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113(20):4853-5.

Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol. 2007;37(12):1191-200.

Brewer CJ, Coates TD, Wood JC. Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major. J Magn Reson Imaging. 2006;29(2):357-64.

Wood JC. History and current impact of cardiac magnetic resonance imaging on the management of iron overload. Circulation. 2009;120(20):1937-9.

St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S, et al. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. J Magn Reson Imaging. 2014;71(6):2215-23.

Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32(2):315-9.

Publicado

2016-07-06

Número

Sección

Artigo Teórico